These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17124048)

  • 1. Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?
    Davies SM
    Hematology Am Soc Hematol Educ Program; 2006; ():111-7. PubMed ID: 17124048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
    Morley KI; Hall WD
    J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics - therapeutic and ethical issues.
    Patowary S
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress and clinical importance on pharmacogenetics in cancer therapy.
    Soh TI; Yong WP; Innocenti F
    Clin Chem Lab Med; 2011 Oct; 49(10):1621-32. PubMed ID: 21950596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promise of psychiatric pharmacogenomics.
    Hamilton SP
    Biol Psychiatry; 2015 Jan; 77(1):29-35. PubMed ID: 25483343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of pharmacogenomics--guided tailored therapy for colorectal cancer].
    Kanai M; Kawaguchi T; Matsumoto S; Matsuda F
    Nihon Rinsho; 2014 Jan; 72(1):23-8. PubMed ID: 24597344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where are we today with personalized medicine?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
    Goetz MP; Ames MM; Weinshilboum RM
    Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pharmacoproteomics in the development of personalized medicine.
    Jain KK
    Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.
    Ansari M; Krajinovic M
    Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics and personalized medicine: wicked problems, ragged edges and ethical precipices.
    Fleck LM
    N Biotechnol; 2012 Sep; 29(6):757-68. PubMed ID: 22433081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
    G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?
    La Caze A
    Pharmacoeconomics; 2005; 23(5):445-7. PubMed ID: 15896096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.